#PokeMet - Twitter Hashtag

almost 5 years ago

Gotta catch them all 🐱 #pokemet Fantastic talk on #sbrt⚡ for oligomet HRPca by @DrAndrewLoblaw @Sunnybrook #RANZCRASM21 @RANZCRcollege @TargetingCancer

Hendo_tan's tweet photo. Gotta catch them all 🐱 #pokemet
Fantastic talk on #sbrt⚡ for oligomet HRPca by @DrAndrewLoblaw @Sunnybrook #RANZCRASM21 @RANZCRcollege @TargetingCancer https://t.co/WagsMHAip5

0

14

3

0

Declan Murphy @declangmurphy

over 6 years ago · Melbourne

What do SABR-gurus @_ShankarSiva @piet_ost talk about when out for a run #GU20?! Plotting the next #pokemet trial? Life on the road? Your top 10 favourite urologists 😂?

Shankar Siva

@_ShankarSiva

over 6 years ago

#GU20 is not all work and no play! Blowing out the cobwebs on a quick run with @piet_ost @TargetingCancer #RadOnc

0

30

5

0

1

11

1

0

Shankar Siva

@_ShankarSiva

over 7 years ago

Nice spin on oligometastatic disease - a review with a biological flavour. Not just your usual excercise in #pokemet 😉 @declangmurphy @ChrisSweens1 @piet_ost @alison_tree #radonc

Docace911 @Docace911

over 7 years ago

Staging the Metastatic Spectrum Through Integration of Clinical and Molecular Features | Journal of Clinical Oncology. Nice review and discussion of where to go next ⁦@UCCancerCenter⁩ ⁦@jasonlukemd⁩ ⁦@DrewMoghanaki⁩ ⁦@drdavidpalma⁩ https://t.co/LHKFqxbvnb

1

15

8

2

0

1

12

2

0

Alastair Lamb @LambAlastair

over 7 years ago

@SeanSachdevMD @piet_ost @dr_jonathant @declangmurphy @DrPaulNguyen @JCO_ASCO These articles by @declangmurphy and me hopefully some helpful thoughts on this: #Dandelion_Theory #Pokemet #Whackamole https://t.co/a2zyyHDjIx https://t.co/0heYepum9t https://t.co/MwgkjP3eE3 …

Alastair Lamb @LambAlastair

almost 9 years ago

PSMA-PET & Dandelions-The Phytological Future of #ProstateCancer staging! @fsgfon https://t.co/GzrUn37oBi Full text: https://t.co/LAB0ZLWchJ

LambAlastair's tweet photo. PSMA-PET & Dandelions-The Phytological Future of #ProstateCancer staging! @fsgfon https://t.co/GzrUn37oBi
Full text: https://t.co/LAB0ZLWchJ https://t.co/hbI1sW4mpj

1

9

7

0

2

1

0

Dr. Andrew Loblaw @DrAndrewLoblaw

about 8 years ago

See our review in TAU of #SABR for #ProstateCancer with Pat Cheung and @DrStanLiu Topics include: - Radiobiology - Oncologic Outcomes - #QOL / toxicity - Dose Escalation - Overall Tx time - Oligomets #PokeMet Link: https://t.co/At1x2ooaf4

DrAndrewLoblaw's tweet photo. See our review in TAU of #SABR for #ProstateCancer with Pat Cheung and @DrStanLiu
Topics include:
- Radiobiology
- Oncologic Outcomes
- #QOL / toxicity
- Dose Escalation
- Overall Tx time
- Oligomets #PokeMet
Link: https://t.co/At1x2ooaf4 https://t.co/9uxvEL3Szp

1

11

3

0

Arun Azad @AzadOncology

about 8 years ago

@Dr_RaviMadan Very good point @Dr_RaviMadan. Somewhat disappointing that metastasis-directed therapy only led to undetectable PSA in 30% of patients. @declangmurphy an example of #POKEMET phenomenon? #pcsm #asco18 @pezaro_c @_ShankarSiva

1

2

1

0

Jonathan Tomaszewski @dr_jonathant

over 8 years ago

This month’s #gyzone case picks up where the STOMP trial left off. Are we any closer to an answer for oligorecurrent prostate cancer? https://t.co/yUxfNe7aHW #radonc #pcsm #pokemet

dr_jonathant's tweet photo. This month’s #gyzone case picks up where the STOMP trial left off. Are we any closer to an answer for oligorecurrent prostate cancer? https://t.co/yUxfNe7aHW #radonc #pcsm #pokemet https://t.co/lf6VZyU7L8

2

15

0

Dr. Andrew Loblaw @DrAndrewLoblaw

over 8 years ago

@piet_ost That’s our phase 2 SABR + 1yr ADT #PokeMet study. Predecessor to Canadian phase 3 of best systemic therapy +\- SABR (trial name not announced yet)

0

2

0

Dr. Andrew Loblaw @DrAndrewLoblaw

over 8 years ago

/2...SWOG IAB study randomized pts after initial 9mo induction - median PSA 35-40 yet 50% didn’t not nadir < 4 to allow randomization. So if you Want IAB, can’t wait until 30+. I also now stage before each cycle of IAB (now with PSMA) and enroll to CROP if oligomets #PokeMet https://t.co/0x0FQvw3s4

Dr. Andrew Loblaw @DrAndrewLoblaw

over 8 years ago

Depends how one defines early. NCIC PR7 (IAB v CAB) showed us waiting until PSA 10-15 was safe (once on IAB). if safe for cycle 2+, why not safe up front? TOAD shows survival advantage for early (stay tuned for PSA thresholds in both arms - combined analysis with ELAAT coming) https://t.co/i9JYYIzw0P

0

1

0

1

2

0

Clive Peedell @cpeedell

over 8 years ago

Tour de force summary of prostate SBRT (primary disease & oligometastatic) by Dr Alison Tree for @SABRconsortium #radonc #SABR2017 #pokemet

0

3

4

0

Piet Ost @piet_ost

almost 9 years ago

@sandraturner49 What disturbs me in PSMA, is that we learn as we go without formal trials. Maybe this is all just lead time bias? #pokemet

1

3

2

0

Alastair Lamb @LambAlastair

almost 9 years ago

@homizargar @declangmurphy @piet_ost Loving the #PokeMet! - esp choice of #Charizard. Had to fight to retrieve phone from #Pokemon-ing son this morning to follow ace #APCC17 👍😎

0

5

0

Mirrors of Medicine

@mirrorsmed

almost 9 years ago

Re-watch the #pokemet battle between @piet_ost and @declangmurphy at #PROSCA17 https://t.co/C4uXHRXUGE

0

1

2

0

Dr. Andrew Loblaw @DrAndrewLoblaw

almost 9 years ago

Also ADT (cont or IAB) +/- doce or abi is standard for M1 ds. Adding #SABR closer to practice standard but we only offer on trial #pokemet https://t.co/19IkgfuPfR

Alison Tree 💙 @alison_tree

almost 9 years ago

@_ShankarSiva @dr_jonathant @DrAndrewLoblaw @apccc17 @piet_ost Depends on patient. Although retrospective, the paper by @piet_ost https://t.co/fMcVS2QUms suggests maybe 7 mo extra PFS with short ADT.

1

3

2

0

1

0